- 专利标题： Xanthine phosphodiesterase V inhibitors
-
申请号： US11852638申请日： 2007-09-10
-
公开(公告)号： US07531544B2公开(公告)日： 2009-05-12
- 发明人: Samuel Chackalamannil , Yuguang Wang , Craig D. Boyle , Andrew W. Stamford
- 申请人： Samuel Chackalamannil , Yuguang Wang , Craig D. Boyle , Andrew W. Stamford
- 申请人地址： US NJ Kenilworth
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： US NJ Kenilworth
- 代理商 Mark W. Russell
- 主分类号： A61K31/522
- IPC分类号： A61K31/522 ; A61P9/12 ; A61P15/10 ; C07D473/04 ; C07D473/06 ; C07D473/08
摘要：
A xanthine phosphodiesterase V inhibitor having the formula (I), with the variables defined herein, which is especially useful for treating male (erectile) and female sexual dysfunction and other physiological disorders: For example, a representative compound of the invention is:
公开/授权文献
- US20080058354A1 Xanthine Phosphodiesterase V Inhibitors 公开/授权日：2008-03-06
信息查询
IPC分类:
